Literature DB >> 23106582

Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients.

Kevin O Leslie1, Carlyne D Cool, Thomas A Sporn, Douglas Curran-Everett, Mark P Steele, Kevin K Brown, Momen M Wahidi, David A Schwartz.   

Abstract

CONTEXT: Familial idiopathic interstitial pneumonia (F-IIP) describes the unexplained occurrence of diffuse parenchymal lung disease in related individuals. Prevailing wisdom suggests that the histopathology of F-IIP is indistinguishable from that of idiopathic pulmonary fibrosis, namely, usual interstitial pneumonia (UIP).
OBJECTIVE: To define the histopathology of F-IIP in lung tissue samples.
DESIGN: Tissue sections from 30 patients with F-IIP, enrolled in a national research program, were evaluated by 3 pulmonary pathologists using 15 predefined histopathologic features. Each feature was recorded independently before a final diagnosis was chosen from a limited list dichotomized between UIP or "not UIP." These 2 groups were then compared to survival.
RESULTS: The consensus diagnosis for the F-IIP cohort was an unclassifiable parenchymal fibrosis (60%), with a high incidence of histopathologic honeycombing, fibroblast foci, and smooth muscle in fibrosis. Usual interstitial pneumonia, strictly defined, was identified in less than half of the F-IIP cases (range, 23%-50%). Interobserver agreement was fair (κ  =  0.37) for 2 observers for the overall diagnosis of UIP. Findings unexpected in UIP were prevalent. The survival for the entire F-IIP cohort was poor, with an estimated mortality of 93% and a median age at death of 60.9 years. Subjects with UIP had a shorter survival and younger age at death.
CONCLUSIONS: Pulmonary fibrosis was the dominant histopathology identified in our patients, but diagnostic features of UIP were seen in less than 50% of the samples. Overall survival was poor, with mortality accelerated apparently by the presence of a UIP pattern of disease.

Entities:  

Mesh:

Year:  2012        PMID: 23106582     DOI: 10.5858/arpa.2011-0627-OAI

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Relevance analysis of clinical and lung function parameters changing and prognosis of idiopathic pulmonary fibrosis.

Authors:  Xueren Li; Shouchun Peng; Luqing Wei; Zhenhua Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  [Interstitial processes of the lungs in childhood].

Authors:  H Popper
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

3.  Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease.

Authors:  Kohei Ikezoe; Tomohiro Handa; Kiminobu Tanizawa; Toyofumi F Chen-Yoshikawa; Takeshi Kubo; Akihiro Aoyama; Hideki Motoyama; Kyoko Hijiya; Shinsaku Tokuda; Yoshinari Nakatsuka; Yuko Yamamoto; Ayako Oshima; Shin-Ichi Harashima; Sonoko Nagai; Toyohiro Hirai; Hiroshi Date; Kazuo Chin
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

4.  Squawks in interstitial lung disease prevalence and causes in a cohort of one thousand patients.

Authors:  Carlos A C Pereira; Maria R Soares; Rafaela Boaventura; Marina D C Castro; Paula S Gomes; Andrea Gimenez; Cesar Fukuda; Milena Cerezoli; Israel Missrie
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

5.  Familial pulmonary fibrosis: a heterogeneous spectrum of presentations.

Authors:  Ana Beatriz Hortense; Marcel Koenigkam Dos Santos; Danilo Wada; Alexandre Todorovic Fabro; Mariana Lima; Silvia Rodrigues; Rodrigo Tocantins Calado; José Baddini-Martinez
Journal:  J Bras Pneumol       Date:  2019-06-10       Impact factor: 2.624

Review 6.  The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis.

Authors:  Riitta Kaarteenaho
Journal:  Respir Res       Date:  2013-04-15

Review 7.  Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.

Authors:  Yutaro Nakamura; Takafumi Suda
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-09-06

8.  The aging lung: tissue telomere shortening in health and disease.

Authors:  Stephanie Everaerts; Elise J Lammertyn; Dries S Martens; Laurens J De Sadeleer; Karen Maes; Aernoud A van Batenburg; Roel Goldschmeding; Coline H M van Moorsel; Lieven J Dupont; Wim A Wuyts; Robin Vos; Ghislaine Gayan-Ramirez; Naftali Kaminski; James C Hogg; Wim Janssens; Geert M Verleden; Tim S Nawrot; Stijn E Verleden; John E McDonough; Bart M Vanaudenaerde
Journal:  Respir Res       Date:  2018-05-11

9.  The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.

Authors:  Hiroshi Ishii; Yoshiaki Kinoshita; Hisako Kushima; Nobuhiko Nagata; Kentaro Watanabe
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

10.  Clinical diagnosis of patients subjected to surgical lung biopsy with a probable usual interstitial pneumonia pattern on high-resolution computed tomography.

Authors:  Regina Celia Carlos Tibana; Maria Raquel Soares; Karin Mueller Storrer; Gustavo de Souza Portes Meirelles; Katia Hidemi Nishiyama; Israel Missrie; Ester Nei Aparecida Martins Coletta; Rimarcs Gomes Ferreira; Carlos Alberto de Castro Pereira
Journal:  BMC Pulm Med       Date:  2020-11-16       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.